Kiniksa Pharmaceuticals to Present at the JMP Securities 2018 Life Sciences Conference

Kiniksa Pharmaceuticals to Present at the JMP Securities 2018 Life Sciences Conference

HAMILTON, Bermuda, June 14, 2018 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq:KNSA) announced today that it will be presenting at the JMP Securities 2018 Life Sciences Conference on Thursday, June 21st, 2018 at 10:30 a.m. Eastern Time at the St. Regis New York in New York City.

A live webcast of Kiniksa’s presentation will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. A replay of the webcast will be available on Kiniksa’s website for 14 days following the conference.

About Kiniksa

Kiniksa is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa has a pipeline of product candidates across various stages of development, currently focused on autoinflammatory and autoimmune conditions. For more information, please visit www.kiniksa.com.

Every Second Counts!™

Kiniksa Investor and Media Contact
Mark Ragosa
(781) 430-8289
[email protected]